(Q39186977)

9 September 2017

title

Evaluating the influence of selection markers on obtaining selected pools and stable cell lines in human cells (English)

1 reference

9 September 2017

Amanda M Lanza

1

1 reference

9 September 2017

Do Soon Kim

series ordinal

2

1 reference

9 September 2017

Hal S Alper

series ordinal

3

1 reference

9 September 2017

publication date

11 April 2013

1 reference

9 September 2017

published in

Biotechnology Journal

1 reference

9 September 2017

volume

8

1 reference

9 September 2017

issue

7

1 reference

9 September 2017

page(s)

811-821

1 reference

Cell culture processes for monoclonal antibody production

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Cell engineering and cultivation of chinese hamster ovary (CHO) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Recent advances in large-scale production of monoclonal antibodies and related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Human cells: new platform for recombinant therapeutic protein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Expression systems for therapeutic glycoprotein production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

The vesicle-trafficking protein munc18b increases the secretory capacity of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Guidelines to cell engineering for monoclonal antibody production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Methods in mammalian cell line engineering: from random mutagenesis to sequence-specific approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

In pursuit of a super producer-alternative paths to high producing recombinant mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Production of recombinant protein therapeutics in cultivated mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Selection methods for high-producing mammalian cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Illegitimate DNA integration in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Integration, amplification and stability of plasmid sequences in CHO cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Plasmid integration, amplification and cytogenetics in CHO cells: questions and comments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: improving the efficiency of cell line generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Resistance to the antibiotic Zeocin by stable expression of the Sh ble gene does not fully suppress Zeocin-induced DNA cleavage in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Mechanism of Puromycin Action: Fate of Ribosomes after Release of Nascent Protein Chains from Polysomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Inhibitors of ribosome functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Expression in mammalian cells of a gene from Streptomyces alboniger conferring puromycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Evaluation of selectable markers for rice transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Evaluation of selectable markers for obtaining stable transformants in the gramineae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Selectable marker genes in transgenic plants: applications, alternatives and biosafety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Characterization of plasmid burden and copy number in Saccharomyces cerevisiae for optimization of metabolic engineering applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

New selectable host-marker systems for multiple genetic manipulations based on TRP1, MET2 and ADE2 in the methylotrophic yeast Hansenula polymorpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Selectable genetic markers for nematode transgenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Phleomycin resistance as a dominant selectable marker in CHO cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Overview of vector design for mammalian gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Effects of methotrexate on transfected DNA stability in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Characterization of a newly derived human sarcoma cell line (HT-1080).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

An efficient homologous recombination vector pTV(I) contains a hot spot for increased recombinant protein expression in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Changes in DNA distributions and ploidy of cho cells as a function of time in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Genetic characterization of CHO production host DG44 and derivative recombinant cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

Using the Cre/lox system for targeted integration into the human genome: loxFAS-loxP pairing and delayed introduction of Cre DNA improve gene swapping efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201200364

21 January 2018

Identifiers

DOI

10.1002/BIOT.201200364

1 reference

release_6ykwajmfrzcytdcvqcnpvlz5se

9 September 2017

Fatcat ID

0 references

1 reference